Package 60760-577-60

{"route": ["ORAL"], "spl_id": "4bd575ae-1a71-7ab9-e063-6394a90a7185", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226"], "spl_set_id": ["92637f92-9d7c-c246-e053-2995a90a0347"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["ST. MARY'S MEDICAL PARK PHARMACY"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-577-60)", "package_ndc": "60760-577-60", "marketing_start_date": "20250513"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-577-90)", "package_ndc": "60760-577-90", "marketing_start_date": "20200110"}], "brand_name": "topiramate", "product_id": "60760-577_4bd575ae-1a71-7ab9-e063-6394a90a7185", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "60760-577", "generic_name": "topiramate", "labeler_name": "ST. MARY'S MEDICAL PARK PHARMACY", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "50 mg/1"}], "application_number": "ANDA078235", "marketing_category": "ANDA", "marketing_start_date": "20190911", "listing_expiration_date": "20271231"}